Clinical Trial: Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barre Syndrome(GREAT)

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806916) titled 'Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barre Syndrome(GREAT)' on Sept. 02.

Brief Summary: The goal of this clinical trial is to evaluate the safety and effectiveness of Efgartigimod in patients with Guillain-Barre syndrome (GBS). The main questions it aims to answer are:

Is Efgartigimod a safe treatment option for GBS patients? Does treatment with Efgartigimod improve patient outcomes?

Participants will:

Take drug Efgartigimod or Intravenous Immunoglobulin during hospitalization Undergo six blood draws in six follow-up study visits to evaluate the concentration of IgG Keep a diary of their symptoms and d...